Clin2
NCT06904287Possibly a fitRecruiting

Magnesium for migraine treatment in adults

Migraine

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests if adding magnesium to a standard migraine medication (prochlorperazine) helps treat migraines more effectively. It could be a good option for adults with migraines who haven't taken these drugs recently.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have been diagnosed with migraines or have headaches with typical migraine features (like throbbing pain, nausea, or one-sided pain).
  • You must be able to speak English and give your permission to participate.
  • You must not be pregnant or allergic to the study drugs.
  • You must not have kidney problems or myasthenia gravis.
  • You must not have taken these study drugs within 48 hours before joining.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07779486Recruiting
Intravenous magnesium for acute headache pain relief

This study compares two doses of intravenous (IV) magnesium to see which is more effective at relieving acute headache pain in the emergency department. It aims to provide a fast and effective treatment option for migraine, tension-type, or cluster headaches.

Monastir
NCT07147972Not yet recruiting· Phase 3
Comparing two preventives for episodic migraine headaches

This trial compares two medicines taken daily to prevent migraine headaches, with the goal of reducing how often they happen.

NCT07646613Recruiting· Phase 2
Testing an inhaled migraine medicine for quick relief

This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.

Phoenix, Arizona
NCT06968429Not yet recruiting
Oral butylphthalide capsules for preventing migraine attacks

This trial tests whether an oral capsule called butylphthalide (also known as NBP) can help prevent migraine attacks in adults who get them regularly. If you have migraines 4–14 days per month, this study may offer a new preventive option.

NCT07634146Not yet recruiting
Dietary supplements for migraine symptoms

This trial tests whether a special dietary supplement regimen can improve quality of life, work productivity, and certain health markers in adults who have migraines. If you have migraines and are willing to take supplements, this study might help you feel better and may offer a natural option.

Lutherville-Timonium, Maryland
NCT07015411Recruiting
Neuro supplements for migraine prevention

This trial tests whether a combination of vitamins and supplements can help prevent migraines. It's for adults who have migraines often (at least 6 days per month) and want to try a non-drug option.

Mechelen

Hear when a new Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.